title: The clinical manifestations of vestibular migraine: A review.
abstract: OBJECTIVE
  To provide an overview of vestibular migraines presentation, pathology, and diagnosis, as well as an update on current diagnostic criteria.
  
  
  METHODS
  A review of the most recent literature on vestibular migraines was performed.
  
  
  RESULTS
  Vestibular migraine is a process with significant impact on the quality of life for those afflicted with the disease, with attacks of spontaneous or positional vertigo and migraine symptoms lasting several minutes to 72h. Inner ear disease can co-exist with migraine and the vestibular symptoms occurring with vestibular migraine can mimic inner ear disorders providing a challenge for clinicians in establishing diagnosis. Recent diagnostic criteria for vestibular migraine proposed by a joint committee of the Bárány Society and the International Headache Society provide an important standard for clinical diagnosis and research endeavor.
  
  
  CONCLUSIONS
  Vestibular migraine is a challenging disease process to both diagnose and treat. Proper diagnosis and treatment requires a thorough understanding of the current literature.
authors.affiliation: The Pennsylvania State University, College of Medicine, Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, 500 University Drive, Hershey, PA, 17033 USA. Electronic address: aoconnell2@hmc.psu.edu.
authors.forename: Ashley P
authors.initials: AP
authors.lastname: O'Connell Ferster
authors.affiliation: Harvard Medical School, Department of Otology & Laryngology, 243 Charles Street, Boston, MA, 02114 USA. Electronic address: Adrian_priesol@meei.harvard.edu.
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Priesol
authors.affiliation: The Pennsylvania State University, College of Medicine, Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, 500 University Drive, Hershey, PA, 17033 USA. Electronic address: hisildak@hmc.psu.edu.
authors.forename: Huseyin
authors.initials: H
authors.lastname: Isildak
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004244:Dizziness / Q000209:etiology / Q000503:physiopathology; D006261:Headache / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008881:Migraine Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D023303:Oxazolidinones / Q000627:therapeutic use; D011788:Quality of Life; D058825:Serotonin 5-HT1 Receptor Agonists / Q000627:therapeutic use; D014363:Tryptamines / Q000627:therapeutic use; D014717:Vertigo / Q000209:etiology / Q000503:physiopathology; D015837:Vestibular Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D023303:Oxazolidinones; D058825:Serotonin 5-HT1 Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan
keywords: Dizziness; Migraine; Vertigo; Vestibular disorders; Vestibular migraine